Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
Clinical trial NCT05547464 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05547464
- Sponsor
- BioNTech SE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2026-03-12
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.